HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-OCT-16 5TQ8 TITLE DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE TITLE 2 (PF-06263276) SUITABLE FOR INHALED AND TOPICAL DELIVERY FOR THE TITLE 3 TREATMENT OF INFLAMMATORY DISEASES OF THE LUNGS AND SKIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 837-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS KINASE, INFLAMMATION, JAK INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.CHRENCIK,P.JONES REVDAT 5 04-OCT-23 5TQ8 1 REMARK REVDAT 4 27-SEP-17 5TQ8 1 REMARK REVDAT 3 08-FEB-17 5TQ8 1 JRNL REVDAT 2 18-JAN-17 5TQ8 1 JRNL REVDAT 1 11-JAN-17 5TQ8 0 JRNL AUTH P.JONES,R.I.STORER,Y.A.SABNIS,F.M.WAKENHUT,G.A.WHITLOCK, JRNL AUTH 2 K.S.ENGLAND,T.MUKAIYAMA,C.M.DEHNHARDT,J.W.COE,S.W.KORTUM, JRNL AUTH 3 J.E.CHRENCIK,D.G.BROWN,R.M.JONES,J.R.MURPHY,T.YEOH,P.MORGAN, JRNL AUTH 4 I.KILTY JRNL TITL DESIGN AND SYNTHESIS OF A PAN-JANUS KINASE INHIBITOR JRNL TITL 2 CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND JRNL TITL 3 TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES JRNL TITL 4 OF THE LUNGS AND SKIN. JRNL REF J. MED. CHEM. V. 60 767 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 27983835 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01634 REMARK 2 REMARK 2 RESOLUTION. 1.59 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 38052 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1911 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 19 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.59 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.18 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2779 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2016 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2625 REMARK 3 BIN R VALUE (WORKING SET) : 0.2006 REMARK 3 BIN FREE R VALUE : 0.2199 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.54 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2390 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 234 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.26610 REMARK 3 B22 (A**2) : 1.62170 REMARK 3 B33 (A**2) : 2.64440 REMARK 3 B12 (A**2) : 0.85390 REMARK 3 B13 (A**2) : 5.51780 REMARK 3 B23 (A**2) : -1.05650 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.194 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.085 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.083 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.084 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.083 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2490 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3362 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 888 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 85 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 361 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2490 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 303 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3026 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.28 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.51 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 1.3256 0.8400 0.3736 REMARK 3 T TENSOR REMARK 3 T11: -0.0443 T22: -0.0531 REMARK 3 T33: -0.0307 T12: -0.0151 REMARK 3 T13: -0.0108 T23: 0.0149 REMARK 3 L TENSOR REMARK 3 L11: 0.5168 L22: 0.3398 REMARK 3 L33: 2.3729 L12: -0.0852 REMARK 3 L13: 0.7914 L23: 0.0404 REMARK 3 S TENSOR REMARK 3 S11: -0.0447 S12: 0.0430 S13: 0.0281 REMARK 3 S21: 0.0392 S22: -0.0495 S23: -0.0257 REMARK 3 S31: -0.1196 S32: 0.1303 S33: 0.0941 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224635. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38072 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.590 REMARK 200 RESOLUTION RANGE LOW (A) : 43.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3TJC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.5, 100 MM SODIUM REMARK 280 ACETATE, 30% PEG-3350, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 835 REMARK 465 SER A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 GLY A 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1011 CD CE NZ REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 LYS A1083 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 976 39.12 -146.69 REMARK 500 ASP A 994 87.34 8.13 REMARK 500 TRP A1106 33.46 -94.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GS A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TQ8 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ7 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ6 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ5 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ4 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ3 RELATED DB: PDB DBREF 5TQ8 A 837 1132 UNP O60674 JAK2_HUMAN 837 1132 SEQADV 5TQ8 GLY A 835 UNP O60674 EXPRESSION TAG SEQADV 5TQ8 SER A 836 UNP O60674 EXPRESSION TAG SEQADV 5TQ8 SER A 1073 UNP O60674 MET 1073 ENGINEERED MUTATION SEQADV 5TQ8 THR A 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 A 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 A 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 A 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 A 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 A 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 A 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 A 298 ASP TYR LEU GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE SEQRES 10 A 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 A 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 A 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 A 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 A 298 ASP LYS GLU TYR TYR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 A 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 A 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 A 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 A 298 LYS GLN GLY GLN SER ILE VAL THR HIS LEU ILE GLU LEU SEQRES 20 A 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 A 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 A 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 A 298 LEU ARG VAL ASP GLN ILE ARG ASP ASN MET ALA GLY HET 7GS A4000 42 HETNAM 7GS {2-[6-(2-ETHYL-5-FLUORO-4-HYDROXYPHENYL)-2H-INDAZOL-3- HETNAM 2 7GS YL]-3,4,6,7-TETRAHYDRO-5H-IMIDAZO[4,5-C]PYRIDIN-5- HETNAM 3 7GS YL}[5-(PIPERIDIN-1-YL)PYRAZIN-2-YL]METHANONE FORMUL 2 7GS C31 H31 F N8 O2 FORMUL 3 HOH *234(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 LEU A 905 1 18 HELIX 3 AA3 GLY A 921 LEU A 925 5 5 HELIX 4 AA4 SER A 936 LYS A 945 1 10 HELIX 5 AA5 GLU A 946 ILE A 948 5 3 HELIX 6 AA6 ASP A 949 LYS A 970 1 22 HELIX 7 AA7 ALA A 978 ARG A 980 5 3 HELIX 8 AA8 PRO A 1017 TYR A 1021 5 5 HELIX 9 AA9 ALA A 1022 SER A 1029 1 8 HELIX 10 AB1 SER A 1032 THR A 1049 1 18 HELIX 11 AB2 GLU A 1052 LYS A 1055 5 4 HELIX 12 AB3 SER A 1056 GLY A 1066 1 11 HELIX 13 AB4 SER A 1073 ASN A 1084 1 12 HELIX 14 AB5 PRO A 1095 TRP A 1106 1 12 HELIX 15 AB6 ASN A 1109 ARG A 1113 5 5 HELIX 16 AB7 SER A 1115 ALA A 1131 1 17 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 TYR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N TYR A1008 SITE 1 AC1 19 GLN A 853 GLN A 854 LEU A 855 LYS A 857 SITE 2 AC1 19 ALA A 880 GLU A 898 LEU A 902 MET A 929 SITE 3 AC1 19 GLU A 930 TYR A 931 LEU A 932 PRO A 933 SITE 4 AC1 19 GLY A 935 LEU A 983 GLY A 993 ASP A 994 SITE 5 AC1 19 PHE A 995 HOH A4177 HOH A4219 CRYST1 36.740 44.980 52.350 104.91 109.59 94.10 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027218 0.001951 0.010764 0.00000 SCALE2 0.000000 0.022289 0.006992 0.00000 SCALE3 0.000000 0.000000 0.021250 0.00000